Cipla | CIPLA - Gross Profit On Sales

Stock Price
1,326.10
Daily Change
-7.20 -0.54%
Monthly
-9.66%
Yearly
-9.93%
Q1 Forecast
1,299.11

Cipla reported INR41.64B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
aTyr Pharma USD 190K 15.57M Sep/2025
Cipla INR 41.64B 6.31B Dec/2025
Dr.Reddys Laboratories INR 51.37B 629M Dec/2025
Sun Pharmaceuticals INR 107.66B 2.05B Sep/2025
UPL INR 55.96B 1.01B Dec/2025